Black Rock Inc. Ligand Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,871,496 shares of LGND stock, worth $280 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,871,496
Previous 2,868,270
0.11%
Holding current value
$280 Million
Previous $210 Million
15.4%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LGND
# of Institutions
247Shares Held
17.5MCall Options Held
61KPut Options Held
7.8K-
Vanguard Group Inc Valley Forge, PA1.93MShares$188 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$98.2 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3967KShares$94.1 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX709KShares$69 Million0.02% of portfolio
-
State Street Corp Boston, MA689KShares$67.1 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.64B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...